Health Economics Unit, School of Health and Population Sciences, Public Health Building, University of Birmingham, Birmingham, UK.
Rheumatology (Oxford). 2011 Sep;50 Suppl 4:iv32-iv38. doi: 10.1093/rheumatology/ker244.
The Birmingham Rheumatoid Arthritis Model (BRAM) has been developed over a number of years to inform several appraisals of biologic drugs by the Technology Appraisals Committee of the UK National Institute for Health and Clinical Excellence. This article describes the processes used in the construction of the different versions of the BRAM.
伯明翰类风湿关节炎模型（BRAM）经过多年的发展，为英国国家卫生与临床优化研究所技术评估委员会对几种生物药物的评估提供了信息。本文介绍了构建 BRAM 不同版本所使用的过程。
